Imberti Jacopo F, Maisano Anna, Rampini Francesca, Minnocci Melania, Bertuglia Filippo, Mantovani Marta, Cherubini Benedetta, Mei Davide A, Ferrara Leonardo, Bonini Niccolò, Valenti Anna Chiara, Vitolo Marco, Longo Giuseppe, Boriani Giuseppe
Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Via del Pozzo 71, 41125 Modena, Italy.
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, 41125 Modena, Italy.
J Clin Med. 2023 Jan 26;12(3):962. doi: 10.3390/jcm12030962.
The prevalence of acute cardiovascular diseases (CVDs) in cancer patients is steadily increasing and represents a significant reason for admission to the emergency department (ED).
We conducted a prospective observational study, enrolling consecutive patients with cancer presenting to a tertiary oncological ED and consequently admitted to the oncology ward. Two groups of patients were identified based on main symptoms that lead to ED presentation: symptoms potentially related to CVD vs. symptoms potentially not related to CVD. The aims of the study were to describe the prevalence of symptoms potentially related to CVD in this specific setting and to evaluate the prevalence of definite CV diagnoses at discharge. Secondary endpoints were new intercurrent in-hospital CV events occurrence, length of stay in the oncology ward, and mid-term mortality for all-cause.
A total of 469 patients (51.8% female, median age 68.0 [59.1-76.3]) were enrolled. One hundred and eighty-six out of 469 (39.7%) presented to the ED with symptoms potentially related to CVD. Baseline characteristics were substantially similar between the two study groups. A discharge diagnosis of CVD was confirmed in 24/186 (12.9%) patients presenting with symptoms potentially related to CVD and in no patients presenting without symptoms potentially related to CVD ( < 0.01). During a median follow-up of 3.4 (1.2-6.5) months, 204 (43.5%) patients died (incidence rate of 10.1 per 100 person/months). No differences were found between study groups in terms of all-cause mortality (hazard ratio [HR]: 0.85, 95% confidence interval [CI] 0.64-1.12), new in-hospital CV events (HR: 1.03, 95% CI 0.77-1.37), and length of stay ( = 0.57).
In a contemporary cohort of cancer patients presenting to a tertiary oncological ED and admitted to an oncology ward, symptoms potentially related to CVD were present in around 40% of patients, but only a minority were actually diagnosed with an acute CVD.
癌症患者中急性心血管疾病(CVD)的患病率正在稳步上升,是急诊科(ED)收治的重要原因。
我们进行了一项前瞻性观察性研究,纳入连续就诊于三级肿瘤急诊科并随后入住肿瘤病房的癌症患者。根据导致患者前往急诊科就诊的主要症状,将患者分为两组:可能与CVD相关的症状组与可能与CVD无关的症状组。本研究的目的是描述在这一特定环境中可能与CVD相关症状的患病率,并评估出院时确诊心血管疾病的患病率。次要终点是住院期间新发并发心血管事件的发生率、在肿瘤病房的住院时间以及全因中期死亡率。
共纳入469例患者(女性占51.8%,中位年龄68.0[59.1 - 76.3])。469例患者中有186例(39.7%)因可能与CVD相关的症状前往急诊科就诊。两个研究组的基线特征基本相似。在因可能与CVD相关症状就诊的186例患者中,有24例(12.9%)出院诊断为CVD,而在无可能与CVD相关症状就诊的患者中无一例确诊(<0.01)。在中位随访3.4(1.2 - 6.5)个月期间,204例(43.5%)患者死亡(发病率为每100人/月10.1例)。在全因死亡率(风险比[HR]:0.85,95%置信区间[CI]0.64 - 1.12)、住院期间新发心血管事件(HR:1.03,95%CI 0.77 - 1.37)和住院时间(P = 0.57)方面,研究组之间未发现差异。
在一个当代队列中,就诊于三级肿瘤急诊科并入住肿瘤病房的癌症患者中,约40%的患者存在可能与CVD相关的症状,但实际被诊断为急性CVD的患者仅占少数。